🇺🇸 FDA
Patent

US 10287584

Compounds and methods for the modulation of COMP

granted A61KA61K31/12A61K31/192

Quick answer

US patent 10287584 (Compounds and methods for the modulation of COMP) held by The Board of Regents of the University of Texas System expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/12, A61K31/192, A61K31/202, A61K31/232